Total: 3 |
|
PMID (PMCID) | ||
---|---|---|
934188 |
MALE | |
Hyperuricosuria due to high-dose pancreatic extract therapy in cystic fibrosis. | ||
Stapleton FB, Kennedy J, Nousia-Arvanitakis S, Linshaw MA. N Engl J Med. 1976;295(5):246-8. |
||
On the basis of this information, we suggest that the minimal effective dose of pancreatic extract should be determined and adhered to for each child with cystic fibrosis to avoid potential renal injury from hyperuricosuria. | ||
934188 |
MALE | |
Hyperuricosuria due to high-dose pancreatic extract therapy in cystic fibrosis. | ||
Stapleton FB, Kennedy J, Nousia-Arvanitakis S, Linshaw MA. N Engl J Med. 1976;295(5):246-8. |
||
Dysuria, uric acid crystalluria and hyperuricosuria developed in a child with cystic fibrosis and normal serum uric acid. | ||
934188 |
MALE | |
Hyperuricosuria due to high-dose pancreatic extract therapy in cystic fibrosis. | ||
Stapleton FB, Kennedy J, Nousia-Arvanitakis S, Linshaw MA. N Engl J Med. 1976;295(5):246-8. |
||
Hyperuricosuria due to high-dose pancreatic extract therapy in cystic fibrosis. |